Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Septerna

11.20.24

In The News, Featured

Up Next

View All

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering...